Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor

Acta Crystallographica. Section D, Biological Crystallography
Jose C ClementeRobert McKenna

Abstract

The malarial parasite continues to be one of the leading causes of death in many developing countries. With the development of resistance to the currently available treatments, the discovery of new therapeutics is imperative. Currently, the plasmepsin enzymes found in the food vacuole of the parasite are a chief target for drug development. Allophenylnorstatine-based compounds originally designed to inhibit HIV-1 protease have shown efficacy against all four plasmepsin enzymes found in the food vacuole of Plasmodium falciparum. In this study, the first crystal structure of P. malariae plasmepsin 4 (PmPM4) bound to the allophenylnorstatine-based compound KNI-764 is described at 3.3 Angstroms resolution. The PmPM4-inhibitor complex crystallized in the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 95.9, b = 112.6, c = 90.4 Angstroms, with two molecules in the asymmetric unit related by a non-crystallographic symmetry operator. The structure was refined to a final R factor of 24.7%. The complex showed the inhibitor in an unexpected binding orientation with allophenylnorstatine occupying the S1' pocket. The P2 group was found outside the S2 pocket, wedged between the flap and a juxtaposed loop. Inhibition analys...Continue Reading

Citations

Jul 3, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Mingzhu ZhaoDong-Qing Wei
Oct 19, 2006·FEBS Letters·Hugo Gutiérrez-de-TeránJohan Aqvist
Apr 28, 2011·Journal of Structural Biology·Prasenjit BhaumikAlla Gustchina
Mar 9, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Manmeet RawatArun Sharma
Jul 6, 2010·Journal of Molecular Biology·Tadashi SatohAlexander Wlodawer
Jun 6, 2009·New Biotechnology·Yasumi HorimotoRickey Y Yada
Mar 17, 2009·Journal of Molecular Biology·Prasenjit BhaumikAlexander Wlodawer
Sep 4, 2008·Archiv der Pharmazie·Jeffrey-Tri NguyenYoshiaki Kiso
Nov 9, 2006·ChemMedChem·Christoph BossDaniel Bur
Jul 17, 2015·Journal of Chemical Information and Modeling·Williams E MirandaPedro A Valiente
Jul 11, 2014·The Biochemical Journal·Nyssa Drinkwater, Sheena McGowan
May 5, 2011·Biochimica Et Biophysica Acta·Prasenjit BhaumikAlexander Wlodawer
Sep 19, 2007·Current Opinion in Structural Biology·P GayathriM R N Murthy
May 6, 2020·The Journal of Biological Chemistry·Armiyaw S NasamuDaniel E Goldberg
Oct 17, 2006·The Journal of Biological Chemistry·Jun LiuDaniel E Goldberg
Nov 6, 2018·Frontiers in Cellular and Infection Microbiology·Cristian Rocha-RoaNéstor Cardona
May 31, 2008·The Journal of Organic Chemistry·Martina Zürcher, François Diederich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.